Skip to main content Back to Top
Advertisement

1/6/2017

Diltiazem Extended-Release Capsules (Twice-Daily Dosing)

Reason for the Shortage

    • Mylan Institutional did not provide a reason for the shortage.

Available Products

    • Diltiazem Hydrochloride oral extended release capsule, Mylan, 120 mg, bottle, 100 count, NDC 00378-6120-01
    • Diltiazem Hydrochloride oral extended release capsule, Mylan, 60 mg, bottle, 100 count, NDC 00378-6060-01
    • Diltiazem Hydrochloride oral extended release capsule, Mylan, 90 mg, bottle, 100 count, NDC 00378-6090-01
    • Diltiazem Hydrochloride oral extended release capsule, Mylan Institutional, 120 mg, unit-dose blister pack, 100 count, NDC 51079-0926-20
    • Diltiazem Hydrochloride oral extended release capsule, Mylan Institutional, 60 mg, unit-dose blister pack, 100 count, NDC 51079-0924-20
    • Diltiazem Hydrochloride oral extended release capsule, Mylan Institutional, 90 mg, unit-dose blister pack, 100 count, NDC 51079-0925-20

Estimated Resupply Dates

    • Mylan Institutional has all diltiazem extended-release capsules available.

Updated

Updated January 6, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Created October 4, 2016 by Leslie Jensen, PharmD, Drug Information Specialist. Copyright 2017, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins